These collective data suggested that proinflammatory mediators characteristic of severe disease, most notably IL-18, limited the induction and recall of highly cytotoxic SARS-CoV-2–specific CD8+ T cells in patients with acute COVID-19. Here, CD8A is linked to COVID-19.